SureshKumarBalasubramanianMD
Hematology • Detroit, MIHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor/ Department of Oncology
Dr. Balasubramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 John R
Detroit, MI 48202Phone+1 313-576-8740
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
Cleveland ClinicPost-Doctoral Fellowship, 2016 - 2017
St Vincent Charity Medical CenterResidency, Internal Medicine, 2012 - 2015
Madras Medical CollegeClass of 2007, MBBS
Certifications & Licensure
MI State Medical License 2017 - 2027
OH State Medical License 2012 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsSelective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.Suresh Kumar Balasubramanian, Asfar S Azmi, Jaroslaw Maciejewski
Leukemia. 2022-03-01 - 306 citationsManagement of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institution...William J. Magnuson, Nataniel H. Lester-Coll, Abraham J. Wu, T. Jonathan Yang, Natalie A. Lockney
Journal of Clinical Oncology. 2017-01-23 - 63 citationsLaser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overviewMayur Sharma, Suresh Kumar Balasubramanian, Danilo Silva, Gene H. Barnett, Alireza M. Mohammadi
Expert Review of Neurotherapeutics. 2016-02-08
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinSuresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabSuresh Kumar Balasubramanian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Brain Metastases Do Not Influence Outcome in Patients with Mutated NSCLCJune 6th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Telugu, Hindi, Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
